Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market
Holding NBRVF?
Track your performance easily

Nabriva Therapeutics (NBRVF) Financial Statements

1,019 Followers

Nabriva Therapeutics Financial Overview

Nabriva Therapeutics's market cap is currently ―. The company's EPS TTM is $-17.779; its P/E ratio is >-0.01; Nabriva Therapeutics is scheduled to report earnings on November 9, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 2.57M$ 7.59M$ 10.57M$ 9.15M$ 9.19M
Gross Profit$ -6.50M$ 3.15M$ -10.10M$ 4.74M$ 4.74M
EBIT$ -12.02M$ -8.51M$ -21.77M$ -10.99M$ -10.49M
EBITDA$ -12.01M$ -8.48M$ -21.75M$ -10.96M$ -10.41M
Net Income Common Stockholders$ -12.06M$ -8.70M$ -22.78M$ -11.51M$ -11.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.18M$ 1.80M$ 12.41M$ 14.65M$ 20.04M
Total Assets$ 10.58M$ 24.34M$ 31.77M$ 48.24M$ 54.89M
Total Debt$ 540.00K$ 542.00K$ 5.22M$ 6.13M$ 7.14M
Net Debt$ -1.64M$ -1.26M$ -7.19M$ -8.52M$ -12.90M
Total Liabilities$ 26.90M$ 28.70M$ 28.47M$ 22.62M$ 20.29M
Stockholders Equity$ -16.32M$ -4.36M$ 3.29M$ 25.62M$ 34.60M
Cash Flow-
Free Cash Flow-$ -5.62M$ -1.63M$ -6.28M$ -13.10M
Operating Cash Flow$ 511.00K$ -5.62M$ -1.63M$ -6.18M$ -13.04M
Investing Cash Flow$ -50.00K$ -3.00K$ -7.00K$ -104.00K$ -116.00K
Financing Cash Flow-$ -4.85M$ -659.00K$ 1.11M$ -792.00K
Currency in USD

Nabriva Therapeutics Earnings and Revenue History

Nabriva Therapeutics Debt to Assets

Nabriva Therapeutics Cash Flow

Nabriva Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis